Activated GLS increased glutaminolysis and upregulated mitochondrial function in prostate cancer cells.[29] In our study, we demonstrated that SUCLG2 knockout led to mitochondrial dysfunction through an increase in the succinylation of mitochondrial proteins and inhibited the function of key metabolic enzymes. This evidence concerns the gene GLS and prostate carcinoma.